Tommy B. Andersson

BioPharmaceuticals R&D
Goeteborg, O, Sweden

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 58 publications

Correction: Li et al. Evaluation of 1β-Hydroxylation of Deoxycholic Acid as a Non-Invasive Urinary Biomarker of CYP3A Activity in the Assessment of Inhibition-Based Drug-Drug Interaction in Healthy Volunteers. J. Pers. Med. 2021, 11, 457.

Correction: Li et al. Evaluation of 1β-Hydroxylation of Deoxycholic Acid as a Non-Invasive Urinary Biomarker of CYP3A Activity in the Assessment of Inhibition-Based Drug-Drug Interaction in Healthy Volunteers. J. Pers. Med. 2021, 11, 457.

Journal: Journal of personalized medicine

Published: May 22, 2026

Normoglycemia and physiological cortisone level maintain glucose homeostasis in a pancreas-liver microphysiological system.

Normoglycemia and physiological cortisone level maintain glucose homeostasis in a pancreas-liver microphysiological system.

Journal: Communications biology

Published: June 18, 2023

Correlations between 4β-hydroxycholesterol and hepatic and intestinal CYP3A4: protein expression, microsomal ex vivo activity, and in vivo activity in patients with a wide body weight range.

Correlations between 4β-hydroxycholesterol and hepatic and intestinal CYP3A4: protein expression, microsomal ex vivo activity, and in vivo activity in patients with a wide body weight range.

Journal: European journal of clinical pharmacology

Published: April 06, 2022

Integrated experimental-computational analysis of a HepaRG liver-islet microphysiological system for human-centric diabetes research.

Integrated experimental-computational analysis of a HepaRG liver-islet microphysiological system for human-centric diabetes research.

Journal: PLoS computational biology

Published: February 10, 2022

Short- and long-term effects of body weight, calorie restriction and gastric bypass on CYP1A2, CYP2C19 and CYP2C9 activity.

Short- and long-term effects of body weight, calorie restriction and gastric bypass on CYP1A2, CYP2C19 and CYP2C9 activity.

Journal: British journal of clinical pharmacology

Published: January 23, 2022

Drug Disposition Protein Quantification in Matched Human Jejunum and Liver From Donors With Obesity.

Drug Disposition Protein Quantification in Matched Human Jejunum and Liver From Donors With Obesity.

Journal: Clinical pharmacology and therapeutics

Published: November 25, 2021

Evaluation of 1β-Hydroxylation of Deoxycholic Acid as a Non-Invasive Urinary Biomarker of CYP3A Activity in the Assessment of Inhibition-Based Drug-Drug Interaction in Healthy Volunteers.

Evaluation of 1β-Hydroxylation of Deoxycholic Acid as a Non-Invasive Urinary Biomarker of CYP3A Activity in the Assessment of Inhibition-Based Drug-Drug Interaction in Healthy Volunteers.

Journal: Journal of personalized medicine

Published: April 13, 2021

Influence of Proteome Profiles and Intracellular Drug Exposure on Differences in CYP Activity in Donor-Matched Human Liver Microsomes and Hepatocytes.

Influence of Proteome Profiles and Intracellular Drug Exposure on Differences in CYP Activity in Donor-Matched Human Liver Microsomes and Hepatocytes.

Journal: Molecular pharmaceutics

Published: March 19, 2021

In Vitro Assessment of the Drug-Drug Interaction Potential of Verinurad and Its Metabolites as Substrates and Inhibitors of Metabolizing Enzymes and Drug Transporters.

In Vitro Assessment of the Drug-Drug Interaction Potential of Verinurad and Its Metabolites as Substrates and Inhibitors of Metabolizing Enzymes and Drug Transporters.

Journal: The Journal of pharmacology and experimental therapeutics

Published: February 03, 2021

A Tribute to Professor Per Artursson - Scientist, Explorer, Mentor, Innovator, and Giant in Pharmaceutical Research.

A Tribute to Professor Per Artursson - Scientist, Explorer, Mentor, Innovator, and Giant in Pharmaceutical Research.

Journal: Journal of pharmaceutical sciences

Published: October 18, 2020

Correlation of Body Weight and Composition With Hepatic Activities of Cytochrome P450 Enzymes.

Correlation of Body Weight and Composition With Hepatic Activities of Cytochrome P450 Enzymes.

Journal: Journal of pharmaceutical sciences

Published: August 14, 2020

Primary Human Hepatocyte Spheroid Model as a 3D In Vitro Platform for Metabolism Studies.

Primary Human Hepatocyte Spheroid Model as a 3D In Vitro Platform for Metabolism Studies.

Journal: Journal of pharmaceutical sciences

Published: August 14, 2020

Showing 1-12 of 58

Last Updated: 09/26/2026